ASTH
Astrana Health, Inc.
Price Chart
Latest Quote
$38.38
+0.00 (+0.00%)
Current Price
| Previous Close | $38.38 |
| Open | $38.64 |
| Day High | $38.97 |
| Day Low | $38.05 |
| Volume | 418,049 |
Stock Information
| Shares Outstanding | 49.58M |
| Total Debt | $1.07B |
| Cash Equivalents | $478.38M |
| Revenue | $3.53B |
| Net Income | $30.23M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $1.90B |
| P/E Ratio | 62.92 |
| EPS (TTM) | $0.61 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.27B |
| Sales | $3.53B |
| Income | $30.23M |
| Book/sh | $16.35 |
| Cash/sh | $9.65 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 1.31 |
| Current Ratio | 1.35 |
| Debt/Eq | 184.46 |
| EPS Growth TTM | 115.70% |
Returns & Margins
| ROA | 3.56% |
| ROE | 5.66% |
| Gross Margin | 10.66% |
| Operating Margin | 3.02% |
| Profit Margin | 0.86% |
Ownership
| Insider Ownership | 22.87% |
| Institutional Ownership | 61.49% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 11.26 |
| P/S | 0.54 |
| P/B | 2.35 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $46.00 |
Technical Indicators
| SMA20 | $38.21 |
| SMA50 | $35.51 |
| SMA200 | $28.21 |
| RSI | 48.99 |
| ATR | 1.4950 |
| Shares Float | 37.57M |
| Short Float | 9.22% |
| Short Ratio | 5.15 |
| Volatility | 0.94 |
| Rel Volume | 0.96 |
Performance History
| Week | +0.24% |
| Month | +0.31% |
| Quarter | +54.76% |
| 6 Months | +63.53% |
| YTD | +52.18% |
| Year | +49.05% |
| 3 Years | +15.88% |
| 5 Years | -10.43% |
| 10 Years | +638.08% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $38.38 | 448,400 |
| 2026-06-15 | $38.38 | 452,300 |
| 2026-06-12 | $38.62 | 520,000 |
| 2026-06-11 | $39.85 | 745,300 |
| 2026-06-10 | $38.73 | 903,700 |
| 2026-06-09 | $38.29 | 474,900 |
| 2026-06-08 | $38.39 | 434,400 |
| 2026-06-05 | $37.99 | 632,800 |
| 2026-06-04 | $37.85 | 547,800 |
| 2026-06-03 | $36.70 | 338,300 |
| 2026-06-02 | $36.91 | 408,800 |
| 2026-06-01 | $37.76 | 413,800 |
| 2026-05-29 | $37.62 | 388,100 |
| 2026-05-28 | $38.33 | 320,500 |
| 2026-05-27 | $38.52 | 347,100 |
| 2026-05-26 | $38.54 | 554,600 |
| 2026-05-22 | $37.85 | 375,900 |
| 2026-05-21 | $37.38 | 427,200 |
| 2026-05-20 | $38.76 | 327,200 |
| 2026-05-19 | $39.30 | 313,900 |
| 2026-05-18 | $38.98 | 491,700 |
About Astrana Health, Inc.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
đ° Latest News
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
StockStory âĸ 2026-06-15T13:24:07Z
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
StockStory âĸ 2026-06-05T18:56:14Z
A Look Back at Healthcare Technology for Providers Stocksâ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
StockStory âĸ 2026-05-26T18:23:28Z
Is Astranaâs Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)?
Simply Wall St. âĸ 2026-05-21T21:16:28Z
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
StockStory âĸ 2026-05-21T03:08:55Z
2 Mooning Stocks Worth Investigating and 1 We Question
StockStory âĸ 2026-05-19T05:16:55Z
5 Revealing Analyst Questions From Astrana Healthâs Q1 Earnings Call
StockStory âĸ 2026-05-17T15:32:55Z
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results
Insider Monkey âĸ 2026-05-14T16:53:48Z
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
StockStory âĸ 2026-05-13T18:44:55Z
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
MarketBeat âĸ 2026-05-13T03:07:46Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,840,239,000 | $1,763,152,000 | $1,171,703,000 | $944,685,000 |
| Cost Of Revenue | $2,840,239,000 | $1,763,152,000 | $1,171,703,000 | $944,685,000 |
| Total Revenue | $3,181,769,000 | $2,034,540,000 | $1,386,661,000 | $1,144,163,000 |
| Operating Revenue | $3,153,493,000 | $2,019,319,000 | $1,377,417,000 | $1,137,996,000 |
| Expenses | ||||
| Interest Expense | $49,928,000 | $33,097,000 | $16,102,000 | $7,920,000 |
| Total Expenses | $3,103,244,000 | $1,945,190,000 | $1,302,048,000 | $1,039,898,000 |
| Other Income Expense | $-1,148,000 | $10,057,000 | $7,119,000 | $-11,705,000 |
| Other Non Operating Income Expenses | $-2,788,000 | $4,875,000 | $6,121,000 | $3,944,000 |
| Net Non Operating Interest Income Expense | $-37,771,000 | $-18,589,000 | $-1,894,000 | $-5,944,000 |
| Interest Expense Non Operating | $49,928,000 | $33,097,000 | $16,102,000 | $7,920,000 |
| Operating Expense | $263,005,000 | $182,038,000 | $130,345,000 | $95,213,000 |
| General And Administrative Expense | $217,256,000 | $154,111,000 | $112,597,000 | $77,670,000 |
| Other Operating Expenses | - | - | - | $-6,167,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $22,487,000 | $43,149,000 | $60,717,000 | $45,171,000 |
| Net Interest Income | $-37,771,000 | $-18,589,000 | $-1,894,000 | $-5,944,000 |
| Interest Income | $12,157,000 | $14,508,000 | $14,208,000 | $1,976,000 |
| Normalized Income | $22,528,344 | $42,697,242 | $63,671,745 | $61,975,090 |
| Net Income From Continuing And Discontinued Operation | $22,487,000 | $43,149,000 | $60,717,000 | $45,171,000 |
| Total Operating Income As Reported | $78,525,000 | $89,350,000 | $84,613,000 | $104,265,000 |
| Net Income Common Stockholders | $22,487,000 | $43,149,000 | $60,717,000 | $45,171,000 |
| Net Income | $22,487,000 | $43,149,000 | $60,717,000 | $45,171,000 |
| Net Income Including Noncontrolling Interests | $24,076,000 | $49,932,000 | $57,849,000 | $45,741,000 |
| Net Income Continuous Operations | $24,076,000 | $49,932,000 | $57,849,000 | $45,741,000 |
| Pretax Income | $39,606,000 | $80,818,000 | $89,838,000 | $86,616,000 |
| Earnings From Equity Interest | $1,708,000 | $4,451,000 | $5,579,000 | $5,622,000 |
| Interest Income Non Operating | $12,157,000 | $14,508,000 | $14,208,000 | $1,976,000 |
| Operating Income | $78,525,000 | $89,350,000 | $84,613,000 | $104,265,000 |
| Depreciation Amortization Depletion Income Statement | $45,749,000 | $27,927,000 | $17,748,000 | $17,543,000 |
| Depreciation And Amortization In Income Statement | $45,749,000 | $27,927,000 | $17,748,000 | $17,543,000 |
| Gross Profit | $341,530,000 | $271,388,000 | $214,958,000 | $199,478,000 |
| Special Income Charges | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $0.46 | $0.90 | $1.29 | $1.08 |
| Basic EPS | $0.46 | $0.91 | $1.30 | $1.09 |
| Other | ||||
| Tax Effect Of Unusual Items | $-26,656 | $279,242 | $-1,626,255 | $-4,466,910 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $135,351,000 | $141,111,000 | $128,269,000 | $133,350,000 |
| Total Unusual Items | $-68,000 | $731,000 | $-4,581,000 | $-21,271,000 |
| Total Unusual Items Excluding Goodwill | $-68,000 | $731,000 | $-4,581,000 | $-21,271,000 |
| Reconciled Depreciation | $45,749,000 | $27,927,000 | $17,748,000 | $17,543,000 |
| EBITDA (Bullshit earnings) | $135,283,000 | $141,842,000 | $123,688,000 | $112,079,000 |
| EBIT | $89,534,000 | $113,915,000 | $105,940,000 | $94,536,000 |
| Diluted Average Shares | $49,369,685 | $47,943,333 | $47,067,442 | $45,415,741 |
| Basic Average Shares | $49,075,727 | $47,416,484 | $46,705,385 | $44,999,083 |
| Diluted NI Availto Com Stockholders | $22,487,000 | $43,149,000 | $60,717,000 | $45,171,000 |
| Minority Interests | $-1,589,000 | $-6,783,000 | $2,868,000 | $-570,000 |
| Tax Provision | $15,530,000 | $30,886,000 | $31,989,000 | $40,875,000 |
| Gain On Sale Of Security | $-68,000 | $731,000 | $-4,581,000 | $-21,271,000 |
| Selling General And Administration | $217,256,000 | $154,111,000 | $112,597,000 | $77,670,000 |
| Other Gand A | $217,256,000 | $154,111,000 | $112,597,000 | $77,670,000 |
| Gain On Sale Of Business | - | - | $0 | $0 |
| Impairment Of Capital Assets | - | - | - | - |
| Provision For Doubtful Accounts | - | - | - | - |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-356,982,000 | $175,288,000 | $263,739,000 | $196,647,000 |
| Total Assets | $2,218,661,000 | $1,354,894,000 | $933,361,000 | $966,213,000 |
| Total Non Current Assets | $1,355,348,000 | $716,398,000 | $471,854,000 | $538,088,000 |
| Other Non Current Assets | $22,528,000 | $16,667,000 | $2,222,000 | $4,556,000 |
| Non Current Note Receivables | $48,724,000 | $51,266,000 | $26,473,000 | $0 |
| Non Current Accounts Receivable | $26,220,000 | $15,943,000 | $15,943,000 | $15,943,000 |
| Goodwill And Other Intangible Assets | $1,136,273,000 | $537,432,000 | $350,479,000 | $345,914,000 |
| Other Intangible Assets | $270,968,000 | $118,179,000 | $71,648,000 | $76,861,000 |
| Current Assets | $863,313,000 | $638,496,000 | $461,507,000 | $428,125,000 |
| Other Current Assets | $26,264,000 | $25,239,000 | $17,450,000 | $14,798,000 |
| Receivables | $407,575,000 | $324,802,000 | $147,752,000 | $119,733,000 |
| Other Receivables | $26,385,000 | $29,496,000 | $1,335,000 | $1,834,000 |
| Taxes Receivable | $1,799,000 | $19,316,000 | $10,657,000 | $0 |
| Loans Receivable | $4,926,000 | $0 | $0 | $3,121,000 |
| Accounts Receivable | $374,465,000 | $275,990,000 | $76,780,000 | $49,631,000 |
| Cash Cash Equivalents And Short Term Investments | $429,474,000 | $288,455,000 | $296,305,000 | $293,594,000 |
| Cash And Cash Equivalents | $429,474,000 | $288,455,000 | $293,807,000 | $288,027,000 |
| Investmentin Financial Assets | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $609,295,000 | $146,219,000 | - | - |
| Total Debt | $1,078,130,000 | $470,678,000 | $321,014,000 | $229,364,000 |
| Long Term Debt And Capital Lease Obligation | $1,022,456,000 | $455,953,000 | $296,261,000 | $224,579,000 |
| Long Term Debt | $990,904,000 | $425,299,000 | $258,939,000 | $203,389,000 |
| Current Debt And Capital Lease Obligation | $55,674,000 | $14,725,000 | $24,753,000 | $4,785,000 |
| Current Debt | $47,865,000 | $9,375,000 | $19,500,000 | $619,000 |
| Other Current Borrowings | $47,865,000 | $9,375,000 | $19,500,000 | $619,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,660,327,000 | $840,726,000 | $522,593,000 | $407,666,000 |
| Total Non Current Liabilities Net Minority Interest | $1,045,054,000 | $475,118,000 | $303,919,000 | $259,056,000 |
| Other Non Current Liabilities | $17,107,000 | $14,610,000 | $3,586,000 | $20,260,000 |
| Non Current Deferred Liabilities | $5,491,000 | $4,555,000 | $4,072,000 | $14,217,000 |
| Non Current Deferred Taxes Liabilities | $5,491,000 | $4,555,000 | $4,072,000 | $14,217,000 |
| Current Liabilities | $615,273,000 | $365,608,000 | $218,674,000 | $148,610,000 |
| Other Current Liabilities | $360,163,000 | $236,518,000 | $125,597,000 | $81,255,000 |
| Current Deferred Liabilities | $2,659,000 | $1,606,000 | $744,000 | $531,000 |
| Payables And Accrued Expenses | $165,163,000 | $90,350,000 | $47,482,000 | $46,738,000 |
| Payables | $160,527,000 | $84,541,000 | $43,075,000 | $44,029,000 |
| Other Payable | $106,692,000 | $61,449,000 | $24,091,000 | $25,309,000 |
| Accounts Payable | $44,842,000 | $15,168,000 | $9,075,000 | $10,473,000 |
| Dividends Payable | - | $638,000 | $638,000 | $664,000 |
| Total Tax Payable | - | - | $0 | $4,279,000 |
| Income Tax Payable | - | - | $0 | $4,279,000 |
| Equity | ||||
| Common Stock Equity | $779,291,000 | $712,720,000 | $614,218,000 | $542,561,000 |
| Total Equity Gross Minority Interest | $558,334,000 | $514,168,000 | $410,768,000 | $558,547,000 |
| Retained Earnings | $308,379,000 | $286,283,000 | $243,134,000 | $182,417,000 |
| Long Term Equity Investment | $25,637,000 | $39,319,000 | $25,774,000 | $40,299,000 |
| Investments In Other Ventures Under Equity Method | $25,637,000 | $39,319,000 | $25,774,000 | $40,299,000 |
| Stockholders Equity | - | - | - | $542,561,000 |
| Other | ||||
| Treasury Shares Number | $10,571,011 | $10,603,849 | $10,584,340 | $10,299,259 |
| Ordinary Shares Number | $48,885,358 | $47,929,872 | $46,843,743 | $46,575,699 |
| Share Issued | $59,456,369 | $58,533,721 | $57,428,083 | $56,874,958 |
| Tangible Book Value | $-356,982,000 | $175,288,000 | $263,739,000 | $196,647,000 |
| Invested Capital | $1,818,060,000 | $1,147,394,000 | $892,657,000 | $746,569,000 |
| Working Capital | $248,040,000 | $272,888,000 | $242,833,000 | $279,515,000 |
| Capital Lease Obligations | $39,361,000 | $36,004,000 | $42,575,000 | $25,356,000 |
| Total Capitalization | $1,770,195,000 | $1,138,019,000 | $873,157,000 | $745,950,000 |
| Minority Interest | $-220,957,000 | $-198,552,000 | $-203,450,000 | $15,986,000 |
| Additional Paid In Capital | $470,863,000 | $426,389,000 | $371,037,000 | $360,097,000 |
| Capital Stock | $49,000 | $48,000 | $47,000 | $47,000 |
| Common Stock | $49,000 | $48,000 | $47,000 | $47,000 |
| Long Term Capital Lease Obligation | $31,552,000 | $30,654,000 | $37,322,000 | $21,190,000 |
| Current Deferred Revenue | $2,659,000 | $1,606,000 | $744,000 | $531,000 |
| Current Capital Lease Obligation | $7,809,000 | $5,350,000 | $5,253,000 | $4,166,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $31,614,000 | $22,409,000 | $20,098,000 | $15,301,000 |
| Current Accrued Expenses | $4,636,000 | $5,809,000 | $4,407,000 | $2,709,000 |
| Dueto Related Parties Current | $8,993,000 | $7,924,000 | $9,271,000 | $3,304,000 |
| Investments And Advances | $28,533,000 | $48,215,000 | $32,170,000 | $42,695,000 |
| Other Investments | $2,896,000 | $8,896,000 | $6,396,000 | $2,396,000 |
| Goodwill | $865,305,000 | $419,253,000 | $278,831,000 | $269,053,000 |
| Net PPE | $93,070,000 | $46,875,000 | $44,567,000 | $128,980,000 |
| Accumulated Depreciation | $-29,674,000 | $-24,688,000 | $-22,876,000 | $-24,047,000 |
| Gross PPE | $122,744,000 | $71,563,000 | $67,443,000 | $153,027,000 |
| Leases | $10,051,000 | $7,746,000 | $5,930,000 | $7,151,000 |
| Construction In Progress | $4,154,000 | $5,901,000 | $340,000 | $12,801,000 |
| Other Properties | $35,738,000 | $32,601,000 | $37,396,000 | $20,444,000 |
| Machinery Furniture Equipment | $42,700,000 | $25,315,000 | $23,777,000 | $21,892,000 |
| Buildings And Improvements | $9,530,000 | $0 | $0 | $58,451,000 |
| Land And Improvements | $20,571,000 | $0 | $0 | $32,288,000 |
| Properties | $0 | $0 | $0 | $0 |
| Preferred Stock | - | $0 | $0 | $0 |
| Duefrom Related Parties Current | - | $50,257,000 | $58,980,000 | $65,147,000 |
| Other Short Term Investments | - | $2,378,000 | $2,498,000 | $5,567,000 |
| Available For Sale Securities | - | - | - | - |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $104,491,000 | $44,167,000 | $39,698,000 | $59,188,000 |
| Operating Activities | ||||
| Operating Cash Flow | $114,597,000 | $52,198,000 | $68,227,000 | $82,128,000 |
| Cash Flow From Continuing Operating Activities | $114,597,000 | $52,198,000 | $68,227,000 | $82,128,000 |
| Operating Gains Losses | - | $-6,849,000 | $-7,026,000 | $-11,228,000 |
| Investing Activities | ||||
| Capital Expenditure | $-10,106,000 | $-8,031,000 | $-28,529,000 | $-22,940,000 |
| Investing Cash Flow | $-538,999,000 | $-192,395,000 | $-65,523,000 | $-7,113,000 |
| Cash Flow From Continuing Investing Activities | $-538,999,000 | $-192,395,000 | $-65,523,000 | $-7,113,000 |
| Net Other Investing Changes | $4,611,000 | $-28,229,000 | $-30,157,000 | $4,067,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-15,429,000 | $-937,000 | $-10,192,000 | $-9,250,000 |
| Financing Cash Flow | $569,346,000 | $135,146,000 | $3,421,000 | $-20,085,000 |
| Cash Flow From Continuing Financing Activities | $569,346,000 | $135,146,000 | $3,421,000 | $-20,085,000 |
| Net Other Financing Charges | $-31,351,000 | $-13,256,000 | $-4,159,000 | $-4,610,000 |
| Cash Dividends Paid | $-7,885,000 | $-4,036,000 | $-62,074,000 | $-14,030,000 |
| Common Stock Dividend Paid | $-7,885,000 | $-4,036,000 | $-62,074,000 | $-14,030,000 |
| Net Common Stock Issuance | $-15,429,000 | $-937,000 | $-10,192,000 | $-9,250,000 |
| Dividends Received Cfi | - | $0 | $0 | $400,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-495,289,000 | $-18,500,000 | $-204,681,000 | $-4,426,000 |
| Issuance Of Debt | $1,119,300,000 | $171,875,000 | $284,527,000 | $3,598,000 |
| Interest Paid Supplemental Data | $45,767,000 | $30,419,000 | $14,251,000 | $6,672,000 |
| End Cash Position | $434,045,000 | $289,101,000 | $294,152,000 | $288,027,000 |
| Beginning Cash Position | $289,101,000 | $294,152,000 | $288,027,000 | $233,097,000 |
| Changes In Cash | $144,944,000 | $-5,051,000 | $6,125,000 | $54,930,000 |
| Common Stock Payments | $-15,429,000 | $-937,000 | $-10,192,000 | $-9,250,000 |
| Net Issuance Payments Of Debt | $624,011,000 | $153,375,000 | $79,846,000 | $-828,000 |
| Net Long Term Debt Issuance | $624,011,000 | $153,375,000 | $79,846,000 | $-828,000 |
| Long Term Debt Payments | $-495,289,000 | $-18,500,000 | $-204,681,000 | $-4,426,000 |
| Long Term Debt Issuance | $1,119,300,000 | $171,875,000 | $284,527,000 | $3,598,000 |
| Net Business Purchase And Sale | $-533,504,000 | $-156,135,000 | $-6,837,000 | $-18,457,000 |
| Sale Of Business | $15,100,000 | $0 | $0 | $0 |
| Purchase Of Business | $-548,604,000 | $-156,135,000 | $-6,837,000 | $-18,457,000 |
| Net PPE Purchase And Sale | $-10,106,000 | $-8,031,000 | $-28,529,000 | $-22,940,000 |
| Purchase Of PPE | $-10,106,000 | $-8,031,000 | $-28,529,000 | $-22,940,000 |
| Change In Working Capital | $-3,098,000 | $-63,613,000 | $-23,388,000 | $-1,955,000 |
| Change In Other Working Capital | $5,326,000 | $-8,622,000 | $-14,477,000 | $6,917,000 |
| Change In Other Current Liabilities | $2,209,000 | $6,265,000 | $11,936,000 | $18,841,000 |
| Change In Other Current Assets | $3,505,000 | $-8,875,000 | $2,864,000 | $-243,000 |
| Change In Payables And Accrued Expense | $-11,693,000 | $-30,432,000 | $-498,000 | $-2,519,000 |
| Change In Payable | $-11,693,000 | $-30,432,000 | $-498,000 | $-2,519,000 |
| Change In Account Payable | $-11,693,000 | $-30,432,000 | $-498,000 | $-2,519,000 |
| Change In Prepaid Assets | $4,718,000 | $-10,854,000 | $-2,956,000 | $818,000 |
| Change In Receivables | $-7,163,000 | $-11,095,000 | $-20,257,000 | $-25,769,000 |
| Changes In Account Receivables | $-9,424,000 | $-35,765,000 | $-20,568,000 | $-33,965,000 |
| Other Non Cash Items | $13,556,000 | $7,665,000 | $6,422,000 | $4,698,000 |
| Stock Based Compensation | $38,601,000 | $34,536,000 | $22,040,000 | $16,101,000 |
| Deferred Tax | $-4,287,000 | $-4,249,000 | $-12,444,000 | $-14,278,000 |
| Deferred Income Tax | $-4,287,000 | $-4,249,000 | $-12,444,000 | $-14,278,000 |
| Depreciation Amortization Depletion | $45,749,000 | $27,927,000 | $17,748,000 | $17,543,000 |
| Depreciation And Amortization | $45,749,000 | $27,927,000 | $17,748,000 | $17,543,000 |
| Net Income From Continuing Operations | $24,076,000 | $49,932,000 | $57,849,000 | $45,741,000 |
| Income Tax Paid Supplemental Data | - | $43,936,000 | $56,567,000 | $47,311,000 |
| Proceeds From Stock Option Exercised | - | $1,026,000 | $1,522,000 | $8,633,000 |
| Net Investment Purchase And Sale | - | $-2,485,000 | $-5,660,000 | $29,817,000 |
| Sale Of Investment | - | $124,000 | $491,000 | $31,671,000 |
| Purchase Of Investment | - | $-2,609,000 | $-6,151,000 | $-1,854,000 |
| Unrealized Gain Loss On Investment Securities | - | $-731,000 | $4,782,000 | $25,506,000 |
| Earnings Losses From Equity Investments | - | $-4,451,000 | $-5,579,000 | $-4,721,000 |
| Gain Loss On Sale Of Business | - | $0 | $-1,246,000 | $-2,272,000 |
| Asset Impairment Charge | - | - | $0 | $0 |
| Gain Loss On Investment Securities | - | - | $-1,447,000 | $-4,235,000 |
| Sale Of PPE | - | - | - | $0 |
| Change In Tax Payable | - | - | - | $-4,470,000 |
| Change In Income Tax Payable | - | - | - | $-4,470,000 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
| Provisionand Write Offof Assets | - | - | - | - |
Fetched: 2026-06-14